The Schall Law Firm Reminds Investors of Class Action Lawsuit Against Telus International LOS ANGELES, CA / ACCESS Newswire / February 1, 2025 The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against TELUS International (Cda) Inc. (“Telus” or “the Company”) (NYSE:TIXT) for violations of ยงยง10(b) and…
The Schall Law Firm Reminds Investors of Class Action Lawsuit Against Novo Nordisk A/S LOS ANGELES, CA / ACCESS Newswire / February 1, 2025 The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Novo Nordisk A/S (“Novo” or “the Company”) (NYSE:NVO) for violations of 10(b) and…
The Schall Law Firm Investigating XBiotech Inc. for Securities Violations LOS ANGELES, CA / ACCESS Newswire / February 1, 2025 The Schall Law Firm, a national shareholder rights litigation firm, has announced that it is investigating claims on behalf of investors of XBiotech Inc. (“XBiotech” or “the Company”) (NASDAQ:XBIT) for violations of the securities laws….
Welcome to The Schall Law Firm Blog! Class Action Lawsuit Against Kyverna Therapeutics, Inc. Announced LOS ANGELES, CA / ACCESS Newswire / February 1, 2025 The Schall Law Firm, a national shareholder rights litigation firm, has filed a class action lawsuit against Kyverna Therapeutics, Inc. (“Kyverna” or “the Company”) (NASDAQ:KYTX) for alleged violations of the…
Welcome to the Wild World of Shareholder Rights Litigation Investigating Claims and Uncovering Truths Picture this: you’re a savvy investor, making all the right moves in the stock market. You’ve done your research, crunched the numbers, and put your hard-earned money into a promising company like Medpace Holdings, Inc. (NASDAQ:MEDP). But wait, what’s this? The…
Chaos in the Stock Market: What’s Going on with Keros Therapeutics, Inc.? Investors Beware! Hey there, fellow investors! If you’ve been keeping up with the latest buzz in the stock market, you’ve probably heard about the recent investigation into Keros Therapeutics, Inc. Apparently, things aren’t looking too good for this company, and investors are advised…
Hey there, fellow investors! Investigating Claims: What’s the Scoop on IGM Biosciences, Inc.? So, apparently Pomerantz LLP is on the case, investigating claims on behalf of investors of IGM Biosciences, Inc. Looks like there might be some juicy drama unfolding with this company, also known as “IGM” (NASDAQ:IGMS). If you’ve got a stake in IGM,…
Let’s talk about Ripple and XRP! Ripple CEO’s Tweet Recap Have you heard about Ripple’s latest quarterly XRP markets report? If not, let me fill you in on the details. Ripple’s chief executive officer, Brad Garlinghouse, recently took to Twitter to share an exciting recap of the biggest milestones achieved by the company and the…
